A comparison of low dose (6 IU/62.5 μg) of Porcine Sequence Corticotropin with standard dose (24IU/250 μg) in diagnosis of adrenal insufficiency.
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2023 - 2026
Project Lead
Dr. Sonali Appaiah
Authors
Dr. Sonali Appaiah
Project Status
ongoing
Project Type
KES